Heptech is a company specialized in the heparin drug industry with expertise in academic, regulatory, industrial, and marketing areas. Our company focuses on quality control analysis, process improvement, and intermediary services for the pharmaceutical market's heparin commercialization, as well as research and development of innovative biological drugs for global introduction in the anticoagulant, oncological, and anti-inflammatory markets. Our pipeline's main products include: 1) a new, unfractionated bovine heparin (UFH) equivalent to the gold standard products of porcine origin; 2) the first low molecular weight bovine heparin (LMWH); and 3) a low anticoagulant bovine heparinoid for use as an anti-metastatic (oncological) and anti-inflammatory drug.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Rua Hélio De Almeida S/n, Sala 13, Cidade Universitária – Ilha De Fundão, Rio De Janeiro,brazil
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://heptech.com.br
- HQ
- Rio de Janeiro
Heptech Biotecnologia Questions
Heptech Biotecnologia's website is http://heptech.com.br
Heptech Biotecnologia's LinkedIn profile is https://br.linkedin.com/company/heptech-biotecnologia
Heptech Biotecnologia has
6 employees.
View email and phone details for 6
employees at Heptech Biotecnologia.
Heptech Biotecnologia's industry is
Biotechnology Research
Heptech Biotecnologia's top competitors are
Grisea Biotecnologia,
Germsure,
Biobeads,
Delta Entech,
Gcell Cultivo 3d,
Agbio Biotecnologia E Comercio,
Novasynth,
Cellpreserve - Centro De Biotecnologia,
Hapiseeds,
Bean Possible.
Heptech Biotecnologia's categories are Biotechnology Research
Heptech Biotecnologia's founding year is 2017
